The artificial intelligence in cardiology market size has grown exponentially in recent years. It will grow from $2.72 billion in 2025 to $3.82 billion in 2026 at a compound annual growth rate (CAGR) of 40.7%. The growth in the historic period can be attributed to rising cardiovascular disease prevalence, early adoption of cardiac imaging software, growth of wearable medical devices, demand for faster diagnosis, expansion of digital healthcare infrastructure.
The artificial intelligence in cardiology market size is expected to see exponential growth in the next few years. It will grow to $15.19 billion in 2030 at a compound annual growth rate (CAGR) of 41.2%. The growth in the forecast period can be attributed to remote patient monitoring adoption, AI driven clinical decision support, personalized cardiology treatments, integration of telecardiology platforms, focus on preventive cardiac care. Major trends in the forecast period include AI based cardiac imaging analysis, growth of predictive cardiology analytics, integration of wearable heart monitoring, automation of arrhythmia detection, expansion of remote cardiac care solutions.
The substantial burden of cardiovascular diseases is anticipated to drive the growth of the artificial intelligence in cardiology market in the coming years. Cardiovascular diseases include all conditions that affect the heart and blood vessels. In cardiology, AI is utilized to identify cardiovascular disorders by supporting electrocardiogram (ECG) analysis and aiding in the detection of conditions such as long QT syndrome and atrial fibrillation. In addition, AI can analyze vast volumes of data from electronic health records, mobile health devices, and imaging systems. For instance, in August 2025, according to the American Cancer Society, a US-based non-profit organization, cardiovascular disease prevalence is projected to rise by 90% between 2025 and 2050. Moreover, in October 2024, as reported by the Centres for Disease Control and Prevention (CDC), a US-based federal health agency, 919,032 deaths were attributed to cardiovascular disease in the United States in 2023, accounting for nearly 1 in every 3 deaths. Hence, the heavy burden of cardiovascular diseases is accelerating the growth of artificial intelligence (AI) in cardiology.
Major companies operating in the artificial intelligence in cardiology market are increasingly emphasizing strategic collaborations to advance cardiovascular research. Strategic partnerships involve companies combining their strengths and resources to achieve shared benefits and success. For example, in October 2023, the Icahn School of Medicine at Mount Sinai, a US-based medical school, announced a collaboration with the Chiba Institute of Technology (CIT), a Japan-based private university. This partnership aims to enhance understanding, prevention, and management of cardiovascular disease while developing innovative approaches to address this global health challenge. Mount SinAI and CIT plan to work together on global clinical studies involving artificial intelligence and interventional cardiology, heart failure, cardiac electrophysiology, cardiac imaging, and preventive cardiology. The collaboration will also emphasize reducing gender and racial bias at the intersection of artificial intelligence and cardiovascular research to improve patient outcomes and care.
In August 2024, Stryker Corporation, a US-based medical technology company, acquired Care.AI for an undisclosed amount. Through this acquisition, Stryker intends to reinforce its digital healthcare ecosystem by integrating Care.ai’s AI-enabled sensor technology and virtual-care workflow solutions into its connected medical device portfolio. Care.AI is a US-based healthcare technology firm that uses artificial intelligence to strengthen patient monitoring and clinical decision-making across cardiology and other medical specialties.
Major companies operating in the artificial intelligence in cardiology market are Microsoft Corporation; International Business Machines Corporation; Siemens Healthineers; Koninklijke Philips; Ultromics Ltd; Bay Labs; Cleerly Inc.; RSIP Vision Ltd.; Idoven; Cardiologs Technologies Inc.; Viz.ai; Aidoc; Arterys Inc.; Zebra Medical Vision; AliveCor; DiA Imaging Analysis; Eko Health Inc.; Cardiomatics; UltraSight; Anumana Inc.; CardiAI Inc.; Caption Health Inc.; HeartFlow Inc.; iRhythm Technologies Inc.; Biofourmis Inc.
North America was the largest region in the artificial intelligence in cardiology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in cardiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial intelligence in cardiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the AI in cardiology market by increasing costs for imported imaging equipment, wearable devices, and diagnostic hardware. These impacts are strongest in hospital and specialty clinic segments, particularly in asia pacific and north america. Elevated equipment prices have affected technology upgrades. However, tariffs are encouraging local device manufacturing, regional supplier development, and software led cardiology innovations.
The artificial intelligence in cardiology market research report is one of a series of new reports that provides artificial intelligence in cardiology market statistics, including artificial intelligence in cardiology industry global market size, regional shares, competitors with a artificial intelligence in cardiology market share, detailed artificial intelligence in cardiology market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in cardiology industry. This artificial intelligence in cardiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Artificial intelligence is applied in cardiology to predict cardiovascular outcomes, identify malignant arrhythmias, and non-invasively diagnose coronary artery disease. Its use encompasses the detection of heart disease, prompt stroke treatment, and the improvement of diagnostic radiology capabilities.
The essential components of artificial intelligence in cardiology include hardware, software solutions, and services. Hardware pertains to the components or delivery mechanisms responsible for storing and executing written instructions from specific software. In cardiology, artificial intelligence hardware is employed in treating various cardiovascular diseases, such as cardiac arrhythmia, stroke, ischemic heart disease, and coronary artery disease (CAD). Life science companies, healthcare payers, and healthcare providers utilize these technologies.
The artificial intelligence in cardiology market consists of revenues earned by entities by providing disease prediction, disease diagnosis, and automation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence market in cardiology also includes sales of smart robots, and imaging tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The artificial intelligence in cardiology market size is expected to see exponential growth in the next few years. It will grow to $15.19 billion in 2030 at a compound annual growth rate (CAGR) of 41.2%. The growth in the forecast period can be attributed to remote patient monitoring adoption, AI driven clinical decision support, personalized cardiology treatments, integration of telecardiology platforms, focus on preventive cardiac care. Major trends in the forecast period include AI based cardiac imaging analysis, growth of predictive cardiology analytics, integration of wearable heart monitoring, automation of arrhythmia detection, expansion of remote cardiac care solutions.
The substantial burden of cardiovascular diseases is anticipated to drive the growth of the artificial intelligence in cardiology market in the coming years. Cardiovascular diseases include all conditions that affect the heart and blood vessels. In cardiology, AI is utilized to identify cardiovascular disorders by supporting electrocardiogram (ECG) analysis and aiding in the detection of conditions such as long QT syndrome and atrial fibrillation. In addition, AI can analyze vast volumes of data from electronic health records, mobile health devices, and imaging systems. For instance, in August 2025, according to the American Cancer Society, a US-based non-profit organization, cardiovascular disease prevalence is projected to rise by 90% between 2025 and 2050. Moreover, in October 2024, as reported by the Centres for Disease Control and Prevention (CDC), a US-based federal health agency, 919,032 deaths were attributed to cardiovascular disease in the United States in 2023, accounting for nearly 1 in every 3 deaths. Hence, the heavy burden of cardiovascular diseases is accelerating the growth of artificial intelligence (AI) in cardiology.
Major companies operating in the artificial intelligence in cardiology market are increasingly emphasizing strategic collaborations to advance cardiovascular research. Strategic partnerships involve companies combining their strengths and resources to achieve shared benefits and success. For example, in October 2023, the Icahn School of Medicine at Mount Sinai, a US-based medical school, announced a collaboration with the Chiba Institute of Technology (CIT), a Japan-based private university. This partnership aims to enhance understanding, prevention, and management of cardiovascular disease while developing innovative approaches to address this global health challenge. Mount SinAI and CIT plan to work together on global clinical studies involving artificial intelligence and interventional cardiology, heart failure, cardiac electrophysiology, cardiac imaging, and preventive cardiology. The collaboration will also emphasize reducing gender and racial bias at the intersection of artificial intelligence and cardiovascular research to improve patient outcomes and care.
In August 2024, Stryker Corporation, a US-based medical technology company, acquired Care.AI for an undisclosed amount. Through this acquisition, Stryker intends to reinforce its digital healthcare ecosystem by integrating Care.ai’s AI-enabled sensor technology and virtual-care workflow solutions into its connected medical device portfolio. Care.AI is a US-based healthcare technology firm that uses artificial intelligence to strengthen patient monitoring and clinical decision-making across cardiology and other medical specialties.
Major companies operating in the artificial intelligence in cardiology market are Microsoft Corporation; International Business Machines Corporation; Siemens Healthineers; Koninklijke Philips; Ultromics Ltd; Bay Labs; Cleerly Inc.; RSIP Vision Ltd.; Idoven; Cardiologs Technologies Inc.; Viz.ai; Aidoc; Arterys Inc.; Zebra Medical Vision; AliveCor; DiA Imaging Analysis; Eko Health Inc.; Cardiomatics; UltraSight; Anumana Inc.; CardiAI Inc.; Caption Health Inc.; HeartFlow Inc.; iRhythm Technologies Inc.; Biofourmis Inc.
North America was the largest region in the artificial intelligence in cardiology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in cardiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial intelligence in cardiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the AI in cardiology market by increasing costs for imported imaging equipment, wearable devices, and diagnostic hardware. These impacts are strongest in hospital and specialty clinic segments, particularly in asia pacific and north america. Elevated equipment prices have affected technology upgrades. However, tariffs are encouraging local device manufacturing, regional supplier development, and software led cardiology innovations.
The artificial intelligence in cardiology market research report is one of a series of new reports that provides artificial intelligence in cardiology market statistics, including artificial intelligence in cardiology industry global market size, regional shares, competitors with a artificial intelligence in cardiology market share, detailed artificial intelligence in cardiology market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in cardiology industry. This artificial intelligence in cardiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Artificial intelligence is applied in cardiology to predict cardiovascular outcomes, identify malignant arrhythmias, and non-invasively diagnose coronary artery disease. Its use encompasses the detection of heart disease, prompt stroke treatment, and the improvement of diagnostic radiology capabilities.
The essential components of artificial intelligence in cardiology include hardware, software solutions, and services. Hardware pertains to the components or delivery mechanisms responsible for storing and executing written instructions from specific software. In cardiology, artificial intelligence hardware is employed in treating various cardiovascular diseases, such as cardiac arrhythmia, stroke, ischemic heart disease, and coronary artery disease (CAD). Life science companies, healthcare payers, and healthcare providers utilize these technologies.
The artificial intelligence in cardiology market consists of revenues earned by entities by providing disease prediction, disease diagnosis, and automation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence market in cardiology also includes sales of smart robots, and imaging tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Artificial Intelligence in Cardiology Market Characteristics
3. Artificial Intelligence in Cardiology Market Supply Chain Analysis
4. Global Artificial Intelligence in Cardiology Market Trends and Strategies
5. Artificial Intelligence in Cardiology Market Analysis of End Use Industries
7. Global Artificial Intelligence in Cardiology Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Artificial Intelligence in Cardiology Total Addressable Market (TAM) Analysis for the Market
9. Artificial Intelligence in Cardiology Market Segmentation
10. Artificial Intelligence in Cardiology Market, Industry Metrics by Country
11. Artificial Intelligence in Cardiology Market Regional and Country Analysis
12. Asia-Pacific Artificial Intelligence in Cardiology Market
13. China Artificial Intelligence in Cardiology Market
14. India Artificial Intelligence in Cardiology Market
15. Japan Artificial Intelligence in Cardiology Market
16. Australia Artificial Intelligence in Cardiology Market
17. Indonesia Artificial Intelligence in Cardiology Market
18. South Korea Artificial Intelligence in Cardiology Market
19. Taiwan Artificial Intelligence in Cardiology Market
20. South East Asia Artificial Intelligence in Cardiology Market
21. Western Europe Artificial Intelligence in Cardiology Market
22. UK Artificial Intelligence in Cardiology Market
23. Germany Artificial Intelligence in Cardiology Market
24. France Artificial Intelligence in Cardiology Market
25. Italy Artificial Intelligence in Cardiology Market
26. Spain Artificial Intelligence in Cardiology Market
27. Eastern Europe Artificial Intelligence in Cardiology Market
28. Russia Artificial Intelligence in Cardiology Market
29. North America Artificial Intelligence in Cardiology Market
30. USA Artificial Intelligence in Cardiology Market
31. Canada Artificial Intelligence in Cardiology Market
32. South America Artificial Intelligence in Cardiology Market
33. Brazil Artificial Intelligence in Cardiology Market
34. Middle East Artificial Intelligence in Cardiology Market
35. Africa Artificial Intelligence in Cardiology Market
37. Artificial Intelligence in Cardiology Market Competitive Landscape and Company Profiles
38. Artificial Intelligence in Cardiology Market Other Major and Innovative Companies
41. Artificial Intelligence in Cardiology Market High Potential Countries, Segments and Strategies
42. Appendix
Executive Summary
Artificial Intelligence In Cardiology Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses artificial intelligence in cardiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for artificial intelligence in cardiology? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence in cardiology market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Component: Hardware; Software Solutions; Services2) By Application: Cardiac Arrhythmia; Stroke; Ischemic Heart Disease Or Coronary Artery Disease (CAD); Other Applications
3) By End-Use: Lifescience Companies; Healthcare Payers; Healthcare Providers
Subsegments:
1) By Hardware: Imaging Devices; Wearable Devices; Diagnostic Equipment2) By Software Solutions: Cardiac Imaging Analysis Software; Predictive Analytics Tools; Patient Management Systems; Telemedicine Platforms
3) By Services: Consulting Services; Integration And Implementation Services; Maintenance And Support Services; Training And Education Services
Companies Mentioned: Microsoft Corporation; International Business Machines Corporation; Siemens Healthineers; Koninklijke Philips; Ultromics Ltd; Bay Labs; Cleerly Inc.; RSIP Vision Ltd.; Idoven; Cardiologs Technologies Inc.; Viz.ai; Aidoc; Arterys Inc.; Zebra Medical Vision; AliveCor; DiA Imaging Analysis; Eko Health Inc.; Cardiomatics; UltraSight; Anumana Inc.; CardiAI Inc.; Caption Health Inc.; HeartFlow Inc.; iRhythm Technologies Inc.; Biofourmis Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Artificial Intelligence in Cardiology market report include:- Microsoft Corporation
- International Business Machines Corporation
- Siemens Healthineers
- Koninklijke Philips
- Ultromics Ltd
- Bay Labs
- Cleerly Inc.
- RSIP Vision Ltd.
- Idoven
- Cardiologs Technologies Inc.
- Viz.ai
- Aidoc
- Arterys Inc.
- Zebra Medical Vision
- AliveCor
- DiA Imaging Analysis
- Eko Health Inc.
- Cardiomatics
- UltraSight
- Anumana Inc.
- CardiAI Inc.
- Caption Health Inc.
- HeartFlow Inc.
- iRhythm Technologies Inc.
- Biofourmis Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.82 Billion |
| Forecasted Market Value ( USD | $ 15.19 Billion |
| Compound Annual Growth Rate | 41.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
